WASHINGTON—AIDS experts are predicting that new tests designed to identify drug-resistant strains of HIV will soon emerge as important tools to help physicians make decisions regarding therapeutic regimens for patients with the infection.
That was the prevailing take-home message from AIDS scientists who gathered here last month for an international workshop, "Clinical Indications of HIV Drug Resistance Monitoring," organized by International Medical Press and The Johns Hopkins School of Medicine.
Stephenson J. HIV Drug Resistance Testing Shows Promise. JAMA. 1999;281(4):309–310. doi:10.1001/jama.281.4.309
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: